These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21219422)

  • 21. Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes.
    Di Bonito P; De Bellis A; Capaldo B; Turco S; Corigliano G; Pace E; Bizzarro A
    Acta Diabetol; 1996 Sep; 33(3):220-4. PubMed ID: 8904929
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parameters associated with residual insulin secretion during the first year of disease in children and adolescents with Type 1 diabetes mellitus.
    Bonfanti R; Bazzigaluppi E; Calori G; Riva MC; Viscardi M; Bognetti E; Meschi F; Bosi E; Chiumello G; Bonifacio E
    Diabet Med; 1998 Oct; 15(10):844-50. PubMed ID: 9796885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes.
    Watkins RA; Evans-Molina C; Terrell JK; Day KH; Guindon L; Restrepo IA; Mirmira RG; Blum JS; DiMeglio LA
    Transl Res; 2016 Feb; 168():96-106.e1. PubMed ID: 26397425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.
    Zanone MM; Catalfamo E; Pietropaolo SL; Rabbone I; Sacchetti C; Cerutti F; Trucco M; Cavallo-Perin P
    Metabolism; 2003 Jan; 52(1):25-9. PubMed ID: 12524658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intact proinsulin and beta-cell function in lean and obese subjects with and without type 2 diabetes.
    Røder ME; Dinesen B; Hartling SG; Houssa P; Vestergaard H; Sodoyez-Goffaux F; Binder C
    Diabetes Care; 1999 Apr; 22(4):609-14. PubMed ID: 10189540
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twenty-four-hour insulin secretion rates, circulating concentrations of fuel substrates and gut incretin hormones in healthy offspring of Type II (non-insulin-dependent) diabetic parents: evidence of several aberrations.
    Nyholm B; Walker M; Gravholt CH; Shearing PA; Sturis J; Alberti KG; Holst JJ; Schmitz O
    Diabetologia; 1999 Nov; 42(11):1314-23. PubMed ID: 10550415
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic beta-cell responses to GLP-1 after near-normalization of blood glucose in patients with type 2 diabetes.
    Asmar M; Højberg PV; Deacon CF; Hare K; Holst JJ; Madsbad S
    Regul Pept; 2010 Feb; 160(1-3):175-80. PubMed ID: 20005261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved glycemic control with no weight increase in patients with type 2 diabetes after once-daily treatment with the long-acting glucagon-like peptide 1 analog liraglutide (NN2211): a 12-week, double-blind, randomized, controlled trial.
    Madsbad S; Schmitz O; Ranstam J; Jakobsen G; Matthews DR;
    Diabetes Care; 2004 Jun; 27(6):1335-42. PubMed ID: 15161785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association of fasting glucagon and proinsulin concentrations with insulin resistance.
    Ferrannini E; Muscelli E; Natali A; Gabriel R; Mitrakou A; Flyvbjerg A; Golay A; Hojlund K;
    Diabetologia; 2007 Nov; 50(11):2342-7. PubMed ID: 17846745
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo measurement and biological characterisation of the diabetes-associated mutant insulin p.R46Q (GlnB22-insulin).
    Støy J; Olsen J; Park SY; Gregersen S; Hjørringgaard CU; Bell GI
    Diabetologia; 2017 Aug; 60(8):1423-1431. PubMed ID: 28478482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitivity and reproducibility of urinary C-peptide as estimate of islet B-cell function in insulin-treated diabetes.
    Gjessing HJ; Matzen LE; Faber OK; Frøland A
    Diabet Med; 1989; 6(4):329-33. PubMed ID: 2524338
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum leptin and its relationship with metabolic variables in Arabs with type 2 diabetes mellitus.
    Al-Shoumer KA; Al-Asousi AA; Doi SA; Vasanthy BA
    Ann Saudi Med; 2008; 28(5):367-70. PubMed ID: 18779635
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal proinsulin/C-peptide ratio in juvenile diabetes.
    Ludvigsson J; Heding L
    Acta Diabetol Lat; 1982; 19(4):351-8. PubMed ID: 6758459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
    Kim MK; Lee HC; Lee SH; Kwon HS; Baek KH; Kim EK; Lee KW; Song KH
    Diabetes Metab Res Rev; 2012 Jul; 28(5):439-46. PubMed ID: 22407971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. GLP-1 Restores Altered Insulin and Glucagon Secretion in Posttransplantation Diabetes.
    Halden TA; Egeland EJ; Åsberg A; Hartmann A; Midtvedt K; Khiabani HZ; Holst JJ; Knop FK; Hornum M; Feldt-Rasmussen B; Jenssen T
    Diabetes Care; 2016 Apr; 39(4):617-24. PubMed ID: 26908914
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disproportionately elevated proinsulin levels precede the onset of insulin-dependent diabetes mellitus in siblings with low first phase insulin responses. The Childhood Diabetes in Finland Study Group.
    Røder ME; Knip M; Hartling SG; Karjalainen J; Akerblom HK; Binder C
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1570-5. PubMed ID: 7989457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial.
    Herold KC; Gitelman SE; Willi SM; Gottlieb PA; Waldron-Lynch F; Devine L; Sherr J; Rosenthal SM; Adi S; Jalaludin MY; Michels AW; Dziura J; Bluestone JA
    Diabetologia; 2013 Feb; 56(2):391-400. PubMed ID: 23086558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of TCF7L2 SNPs with age at onset of type 2 diabetes and proinsulin/insulin ratio but not with glucagon-like peptide 1.
    Silbernagel G; Renner W; Grammer TB; Hügl SR; Bertram J; Kleber ME; Hoffmann MM; Winkelmann BR; März W; Boehm BO
    Diabetes Metab Res Rev; 2011 Jul; 27(5):499-505. PubMed ID: 21384500
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine secretory reserve and proinsulin processing in recipients of islet of langerhans versus whole pancreas transplants.
    Elkhafif NM; Borot S; Morel P; Demuylder-Mischler S; Giovannoni L; Toso C; Bosco D; Berney T
    Diabetes Care; 2013 Nov; 36(11):3726-31. PubMed ID: 24041681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of vildagliptin and glimepiride: effects on glycaemic control, fat tolerance and inflammatory markers in people with type 2 diabetes.
    Derosa G; Bonaventura A; Bianchi L; Romano D; Fogari E; D'Angelo A; Maffioli P
    Diabet Med; 2014 Dec; 31(12):1515-23. PubMed ID: 24824633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.